Recent research focusing on Semaglutide at a dosage of 30mg is shedding new light on its potential effects. Initial findings suggest that this higher dosage may amplify the drug's ability to control blood sugar, potentially offering improved outcomes for individuals with type 2 diabetes. Further investigation is underway to fully understand the lon